Povetacicept Cuts Proteinuria in IgAN: Richard Lafayette, MD, FACP
In an interview with The American Journal of Managed Care®, Lafayette discussed how povetacicept works, what the interim findings mean for kidney outcomes, and how the safety profile compares with placebo. Lafayette explained that povetacicept is novel because of a…